The Effect of Platelet-Rich Plasma in Hair Regrowth: A Randomized Placebo-Controlled Trial

被引:228
|
作者
Gentile, Pietro [1 ,3 ]
Garcovich, Simone [4 ]
Bielli, Alessandra [2 ]
Scioli, Maria Giovanna [2 ]
Orlandi, Augusto [2 ]
Cervelli, Valerio [1 ]
机构
[1] Univ Roma Tor Vergata, Dept Plast & Reconstruct Surg, Rome, Italy
[2] Univ Roma Tor Vergata, Inst Pathol Anat, Rome, Italy
[3] Catholic Univ, Dept Plast & Reconstruct Surg, Tirana, Albania
[4] Univ Cattolica Sacro Cuore, Inst Dermatol, I-00168 Rome, Italy
关键词
Autologous; Aging; Clinical translations; Clinical trials; ENDOTHELIAL GROWTH-FACTOR; FACTOR VEGF; EXPRESSION; APOPTOSIS; CELLS; DIFFERENTIATION; ANGIOGENESIS; FINASTERIDE; MINOXIDIL;
D O I
10.5966/sctm.2015-0107
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Platelet-rich plasma (PRP) has emerged as a new treatment modality in regenerative plastic surgery, and preliminary evidence suggests that it might have a beneficial role in hair regrowth. Here, we report the results of a randomized, evaluator-blinded, placebo-controlled, half-head group study to compare, with the aid of computerized trichograms, hair regrowth with PRP versus placebo. The safety and clinical efficacy of autologous PRP injections for pattern hair loss were investigated. PRP, prepared from a small volume of blood, was injected on half of the selected patients' scalps with pattern hair loss. The other half was treated with placebo. Three treatments were administered to each patient at 30-day intervals. The endpoints were hair regrowth, hair dystrophy as measured by dermoscopy, burning or itching sensation, and cell proliferation as measured by Ki67 evaluation. Patients were followed for 2 years. Of the 23 patients enrolled, 3 were excluded. At the end of the 3 treatment cycles, the patients presented clinical improvement in the mean number of hairs, with a mean increase of 33.6 hairs in the target area, and a mean increase in total hair density of 45.9 hairs per cm(2) compared with baseline values. No side effects were noted during treatment. Microscopic evaluation showed the increase of epidermis thickness and of the number of hair follicles 2 weeks after the last PRP treatment compared with baseline value (p < .05). We also observed an increase of Ki67(+) keratinocytes in the epidermis and of hair follicular bulge cells, and a slight increase of small blood vessels around hair follicles in the treated skin compared with baseline (p < .05). Relapse of androgenic alopecia was not evaluated in all patients until 12 months after the last treatment. After 12 months, 4 patients reported progressive hair loss; this was more evident 16 months after the last treatment. Those four patients were re-treated. Our data clearly highlight the positive effects of PRP injections on male pattern hair loss and absence of major side effects. PRP may serve as a safe and effective treatment option against hair loss; more extensive controlled studies are needed.
引用
收藏
页码:1317 / 1323
页数:7
相关论文
共 50 条
  • [1] The effect of autologous activated platelet-rich plasma injection on female pattern hair loss: A randomized placebo-controlled study
    Tawfik, Abeer Attia
    Osman, Mai Abdel Raouf
    JOURNAL OF COSMETIC DERMATOLOGY, 2018, 17 (01) : 47 - 53
  • [2] The Addition of Platelet-Rich Plasma to Facial Lipofilling: A Double-Blind, Placebo-Controlled, Randomized Trial
    Ozer, Kadri
    Atan, Oguz
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2018, 142 (05) : 795E - 796E
  • [3] PLATELET-RICH PLASMA INJECTION FOR THE TREATMENT OF STRESS URINARY INCONTINENCE IN FEMALES: A RANDOMIZED PLACEBO-CONTROLLED TRIAL
    Ashton, Leah
    Nataksuka, Hannah
    Johnson, Colin
    Kenne, Kimberly
    Kreder, Karl
    Kruse, Ryan
    Ten Eyck, Patrick
    Takacs, Elizabeth
    Vollstedt, Annah
    JOURNAL OF UROLOGY, 2024, 211 (05): : E383 - E383
  • [4] The Addition of Platelet-Rich Plasma to Facial Lipofilling: A Double-Blind, Placebo-Controlled, Randomized Trial
    Willemsen, Joep C. N.
    Van Dongen, Joris
    Spiekman, Maroesjka
    Vermeulen, Karin M.
    Harmsen, Martin C.
    van der Lei, Berend
    Stevens, H. P. Jeroen
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2018, 141 (02) : 331 - 343
  • [5] PLATELET-RICH PLASMA AND PLASMA FOR TREATMENT OF KNEE OSTEOARTHRITIS: A DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED CLINICAL TRIAL
    Dorio, M.
    Pereira, R. M.
    Oliveira, R. M.
    Luz, A. G.
    Fuller, R.
    OSTEOARTHRITIS AND CARTILAGE, 2019, 27 : S481 - S482
  • [6] Platelet-rich Plasma for Androgenetic Alopecia Treatment: A Randomized Placebo-controlled Pilot Study
    Gressenberger, Paul
    Pregartner, Gudrun
    Gary, Thomas
    Wolf, Peter
    Kopera, Daisy
    ACTA DERMATO-VENEREOLOGICA, 2020, 100 : 1 - 7
  • [7] Reply: The Addition of Platelet-Rich Plasma to Facial Lipofilling: A Double-Blind, Placebo-Controlled, Randomized Trial
    van Dongen, Joris A.
    Willemsen, Joep C. N.
    Spiekman, Maroesjka
    Vermeulen, Karin M.
    Harmsen, Martin C.
    Stevens, Hieronymus P.
    van der Lei, Berend
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2018, 142 (05) : 796E - 798E
  • [8] PLATELET-RICH PLASMA (PRP) IMPROVES ERECTILE FUNCTION: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL
    Poulios, E.
    Mykoniatis, I
    Pyrgidis, N.
    Zilotis, F.
    Kapoteli, V
    Kotsiris, D.
    Kalyvianakis, D.
    Hatzichristou, D.
    JOURNAL OF SEXUAL MEDICINE, 2022, 19 (05): : S157 - S158
  • [9] Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial
    Masterson, Thomas A.
    Molina, Manuel
    Ledesma, Braian
    Zucker, Isaac
    Saltzman, Russell
    Ibrahim, Emad
    Han, Sunwoo
    Reis, Isildinha M.
    Ramasamy, Ranjith
    JOURNAL OF UROLOGY, 2023, 210 (01): : 154 - 161
  • [10] Treatment of Lateral Epicondylitis With Platelet-Rich Plasma, Glucocorticoid, or Saline A Randomized, Double-Blind, Placebo-Controlled Trial
    Krogh, Thoger Persson
    Fredberg, Ulrich
    Stengaard-Pedersen, Kristian
    Christensen, Robin
    Jensen, Pia
    Ellingsen, Torkell
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2013, 41 (03): : 625 - 635